BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16441650)

  • 1. Spontaneous repigmentation of vitiligo in an untreated HIV-positive patient.
    Grandhe NP; Dogra S; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):234-5. PubMed ID: 16441650
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitiligo in a patient associated with human immunodeficiency virus infection and repigmentation under antiretroviral therapy.
    Seyedalinaghi SA; Karami N; Hajiabdolbaghi M; Hosseini M
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):840-1. PubMed ID: 19453806
    [No Abstract]   [Full Text] [Related]  

  • 3. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
    Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional study of spontaneous repigmentation in vitiligo.
    Taneja N; Sreenivas V; Sahni K; Gupta V; Ramam M
    Indian J Dermatol Venereol Leprol; 2020; 86(3):240-250. PubMed ID: 31793491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repigmentation of skin and hairs in stable vitiligo by transplantation of autologous melanocytes in fibrin suspension.
    Hartmann A; Broecker EB; Hamm H
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):624-6. PubMed ID: 18410624
    [No Abstract]   [Full Text] [Related]  

  • 6. Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir.
    Dogra S; Kumar B
    Dermatol Online J; 2005 Dec; 11(3):30. PubMed ID: 16409926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pimecrolimus cream in repigmentation of vitiligo.
    Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
    Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo.
    Chimento SM; Newland M; Ricotti C; Nistico S; Romanelli P
    J Drugs Dermatol; 2008 Mar; 7(3):258-63. PubMed ID: 18380207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple quantitative assessment for repigmentation in vitiligo.
    Sohail A; Vaqas B; Bodeker G; Ryan T
    Int J Dermatol; 2012 Mar; 51(3):360-1. PubMed ID: 22348581
    [No Abstract]   [Full Text] [Related]  

  • 10. Surgical repigmentation of leukotrichia in localized vitiligo.
    Laxmisha C; Kumari R; Thappa DM
    Dermatol Surg; 2006 Jul; 32(7):981-2. PubMed ID: 16875488
    [No Abstract]   [Full Text] [Related]  

  • 11. A rare repigmentation pattern in a vitiligo patient: a clue to an epidermal stem-cell reservoir of melanocytes?
    Davids LM; du Toit E; Kidson SH; Todd G
    Clin Exp Dermatol; 2009 Mar; 34(2):246-8. PubMed ID: 18828846
    [No Abstract]   [Full Text] [Related]  

  • 12. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma.
    Vanscheidt W; Hunziker T
    Dermatology; 2009; 218(4):342-3. PubMed ID: 19174603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent component analysis for assessing therapeutic response in vitiligo skin disorder.
    Fadzil MH; Norashikin S; Suraiya HH; Nugroho H
    J Med Eng Technol; 2009; 33(2):101-9. PubMed ID: 19205989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.
    Saraceno R; Nisticò SP; Capriotti E; Chimenti S
    Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study.
    Lahiri K; Malakar S; Sarma N; Banerjee U
    Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion.
    Hartmann A; Bröcker EB; Hamm H
    J Dtsch Dermatol Ges; 2008 May; 6(5):383-5. PubMed ID: 18042249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous repigmentation in vitiligo: why it is important.
    Malakar S; Lahiri K
    Int J Dermatol; 2006 Apr; 45(4):478-9. PubMed ID: 16650185
    [No Abstract]   [Full Text] [Related]  

  • 19. Repigmentation of vitiligo during efalizumab.
    Wakkee M; Assen YJ; Thio HB; Neumann HA
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S57-8. PubMed ID: 18625392
    [No Abstract]   [Full Text] [Related]  

  • 20. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
    Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.